Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by QIAGEN N.V. < Previous 1 2 Next > QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results March 13, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug March 09, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing March 01, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework February 14, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups February 07, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs January 17, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast January 17, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases January 05, 2023 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer December 13, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance November 21, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook November 07, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast October 21, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System September 15, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug September 14, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Issues 2021 Sustainability Report August 18, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency August 15, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service July 27, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook July 26, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases July 19, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast July 07, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks June 01, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label May 19, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels May 16, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. May 11, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Proposes Expansion of Supervisory Board May 11, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System May 05, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook April 26, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN N.V. to release results for Q1 2022 and hold Webcast April 20, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB March 24, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN QIAGEN Announces 20-F Annual Report Filing for 2021 Results March 14, 2022 From QIAGEN N.V. Via Business Wire Tickers QGEN < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.